These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30413924)

  • 1. Evaluation of the performance of extreme patient-reported outcomes as surrogate markers for fibromyalgia in axial spondyloarthritis.
    Santos-Faria D; Dougados M; Gossec L; Perrot S; Moltó A
    Rheumatol Int; 2019 Jan; 39(1):141-146. PubMed ID: 30413924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study.
    Moltó A; Etcheto A; Gossec L; Boudersa N; Claudepierre P; Roux N; Lemeunier L; Martin A; Sparsa L; Coquerelle P; Soubrier M; Perrot S; Dougados M
    Ann Rheum Dis; 2018 Apr; 77(4):533-540. PubMed ID: 29183878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology Biologics Register for Ankylosing Spondylitis.
    Provan SA; Dean LE; Jones GT; Macfarlane GJ
    Rheumatology (Oxford); 2021 Sep; 60(9):4121-4129. PubMed ID: 34469570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register.
    Macfarlane GJ; MacDonald RIR; Pathan E; Siebert S; Gaffney K; Choy E; Packham J; Martin KR; Haywood K; Sengupta R; Atzeni F; Jones GT
    Rheumatology (Oxford); 2018 Nov; 57(11):1982-1990. PubMed ID: 30053166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice.
    Wach J; Letroublon MC; Coury F; Tebib JG
    J Rheumatol; 2016 Nov; 43(11):2056-2063. PubMed ID: 27633820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of whether extremely high enthesitis or Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) scores suggest fibromyalgia and confound the anti-TNF response in early non-radiographic axial spondyloarthritis.
    Dougados M; Logeart I; Szumski A; Coindreau J; Jones H
    Clin Exp Rheumatol; 2017; 35 Suppl 105(3):50-53. PubMed ID: 28240587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis.
    Bello N; Etcheto A; Béal C; Dougados M; Moltó A
    Arthritis Res Ther; 2016 Feb; 18():42. PubMed ID: 26860612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF-α blockers treatment.
    Meghnathi B; Claudepierre P; Dougados M; Moltó A
    Clin Exp Rheumatol; 2018; 36(6):1043-1048. PubMed ID: 30183594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
    van der Heijde D; Dougados M; Landewé R; Sieper J; Maksymowych WP; Rudwaleit M; Van den Bosch F; Braun J; Mease PJ; Kivitz AJ; Walsh J; Davies O; Bauer L; Hoepken B; Peterson L; Deodhar A
    Rheumatology (Oxford); 2017 Sep; 56(9):1498-1509. PubMed ID: 28498975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
    Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
    J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with tumor necrosis factor inhibitors in axial spondyloarthritis: comparison between private rheumatology practices and academic centers in a large observational cohort.
    Ciurea A; Weber U; Stekhoven D; Scherer A; Tamborrini G; Bernhard J; Toniolo M; Villiger PM; Zufferey P; Kissling RO; Michel BA; Exer P;
    J Rheumatol; 2015 Jan; 42(1):101-5. PubMed ID: 25362654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis.
    Baraliakos X; Regel A; Kiltz U; Menne HJ; Dybowski F; Igelmann M; Kalthoff L; Krause D; Saracbasi-Zender E; Schmitz-Bortz E; Braun J
    Rheumatology (Oxford); 2018 Sep; 57(9):1541-1547. PubMed ID: 28968885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ACR 2010 fibromyalgia criteria fulfillment on disease activity evaluation in patients with axial spondyloarthritis treated with infliximab.
    Dantu A; Michaud J; Bréhier Q; Banse C; Avenel G; Lequerré T; Pouplin S; Vittecoq O; Verdet M
    Joint Bone Spine; 2019 Jan; 86(1):113-114. PubMed ID: 29680208
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibromyalgia in Spondyloarthritis: Prevalence and Effect on Disease Activity and Treatment.
    Olfa S; Bouden S; Sahli M; Tekaya AB; Rouached L; Rawdha T; Mahmoud I; Abdelmoula L
    Curr Rheumatol Rev; 2023; 19(2):214-221. PubMed ID: 36056847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of standardized patient reported outcomes developed for spondyloarthritis in primary and concomitant forms of fibromyalgia.
    Tsiami S; Dukatz P; Gkelaki M; Sewerin P; Kiltz U; Baraliakos X
    Arthritis Res Ther; 2024 Jul; 26(1):141. PubMed ID: 39061060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extremely poor patient-reported outcomes are associated with lack of clinical response and decreased retention rate of tumour necrosis factor inhibitor treatment in patients with axial spondyloarthritis.
    Krabbe S; Glintborg B; Østergaard M; Hetland ML
    Scand J Rheumatol; 2019 Mar; 48(2):128-132. PubMed ID: 30102111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is fibromyalgia frequency increasing in axial spondyloarthritis? Association with fibromyalgia and biological therapies.
    Sayın S; Yurdakul FG; Sivas F; Bodur H
    Rheumatol Int; 2020 Nov; 40(11):1835-1841. PubMed ID: 32767083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tender to touch-Prevalence and impact of concomitant fibromyalgia and enthesitis in spondyloarthritis: An ancillary analysis of the ASAS PerSpA study.
    Fitzgerald GE; Maguire S; Lopez-Medina C; Dougados M; O'Shea FD; Haroon N
    Joint Bone Spine; 2022 Nov; 89(6):105420. PubMed ID: 35636706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fibromyalgia on the disease activity and treatment of patients with axial spondyloarthritis.
    Gao R
    J Musculoskelet Neuronal Interact; 2021 Sep; 21(3):440-446. PubMed ID: 34465685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
    Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
    J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.